Treatment with a cocktail of AZD4547, a pan FGFR antagonist, and teriparatide acetate, an osteoporosis drug and PTH agonist, resulted in reduced serum Ca2+, increased mineralization and increased size of certain cranial skeletal elements, including the mandible, in ta2 embryos. The gene discussed is PTH; the disease is osteoporosis.